Details of the Drug

General Information of Drug (ID: DMMUR6D)

• Drug Name: C4.4a-ADC

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Cross-matching ID: TTD ID: D05YRP

References

• [1] Clinical pipeline report, company report or official report of Bayer HealthCare Pharmaceuticals.